RBA Wealth Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.8M Sell
63,308
-3,512
-5% -$377K 2.53% 9
2025
Q1
$6.74M Sell
66,820
-583
-0.9% -$58.8K 2.67% 7
2024
Q4
$6.02M Sell
67,403
-1,053
-2% -$94.1K 2.29% 10
2024
Q3
$5.74M Buy
68,456
+1,210
+2% +$101K 2.21% 14
2024
Q2
$5.18M Sell
67,246
-2,217
-3% -$171K 2.08% 18
2024
Q1
$4.76M Sell
69,463
-1,220
-2% -$83.6K 1.93% 23
2023
Q4
$4.09M Sell
70,683
-371
-0.5% -$21.4K 1.78% 29
2023
Q3
$3.75M Buy
71,054
+936
+1% +$49.4K 1.81% 26
2023
Q2
$3.79M Buy
70,118
+685
+1% +$37.1K 1.77% 28
2023
Q1
$3.47M Buy
69,433
+2,302
+3% +$115K 1.73% 32
2022
Q4
$3.11M Buy
67,131
+2,521
+4% +$117K 1.63% 32
2022
Q3
$2.5M Buy
64,610
+923
+1% +$35.7K 1.44% 38
2022
Q2
$2.37M Buy
63,687
+2,541
+4% +$94.7K 1.32% 39
2022
Q1
$2.71M Buy
61,146
+5,950
+11% +$264K 1.3% 38
2021
Q4
$2.35M Buy
55,196
+9,537
+21% +$405K 1.11% 42
2021
Q3
$1.98M Buy
45,659
+1,696
+4% +$73.6K 4.78% 9
2021
Q2
$1.88M Buy
43,963
+995
+2% +$42.5K 3.99% 10
2021
Q1
$1.66M Buy
42,968
+3,128
+8% +$121K 1.41% 30
2020
Q4
$1.43M Buy
39,840
+5,996
+18% +$216K 0.86% 50
2020
Q3
$1.29M Buy
33,844
+3,971
+13% +$152K 0.87% 49
2020
Q2
$1.05M Buy
29,873
+3,719
+14% +$131K 0.76% 49
2020
Q1
$853K Buy
26,154
+10,377
+66% +$338K 0.74% 48
2019
Q4
$712K Buy
15,777
+3,411
+28% +$154K 0.49% 52
2019
Q3
$503K Buy
12,366
+6,520
+112% +$265K 0.38% 56
2019
Q2
$251K Buy
+5,846
New +$251K 0.19% 75